101 related articles for article (PubMed ID: 11813576)
1. Differential expression of RAGE in human pancreatic carcinoma cells.
Takada M; Koizumi T; Toyama H; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2001; 48(42):1577-8. PubMed ID: 11813576
[TBL] [Abstract][Full Text] [Related]
2. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Takada M; Hirata K; Ajiki T; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2004; 51(58):928-30. PubMed ID: 15239215
[TBL] [Abstract][Full Text] [Related]
3. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.
Hirata K; Takada M; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2003; 50(53):1205-7. PubMed ID: 14571699
[TBL] [Abstract][Full Text] [Related]
4. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
5. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
[TBL] [Abstract][Full Text] [Related]
6. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
Wang L; Li S; Jungalwala FB
J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
[TBL] [Abstract][Full Text] [Related]
7. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
8. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
Kuniyasu H; Chihara Y; Takahashi T
Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
Sasahira T; Kirita T; Bhawal UK; Yamamoto K; Ohmori H; Fujii K; Kuniyasu H
Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
[TBL] [Abstract][Full Text] [Related]
11. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R
Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells.
Takada M; Ku Y; Toyama H; Suzuki Y; Kuroda Y
Hepatogastroenterology; 2002; 49(46):928-31. PubMed ID: 12143244
[TBL] [Abstract][Full Text] [Related]
13. Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma.
Schraml P; Bendik I; Ludwig CU
Cancer Res; 1997 Sep; 57(17):3669-71. PubMed ID: 9288769
[TBL] [Abstract][Full Text] [Related]
14. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
Allmen EU; Koch M; Fritz G; Legler DF
Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
[TBL] [Abstract][Full Text] [Related]
15. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products and age-related macular degeneration.
Howes KA; Liu Y; Dunaief JL; Milam A; Frederick JM; Marks A; Baehr W
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3713-20. PubMed ID: 15452081
[TBL] [Abstract][Full Text] [Related]
18. Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma.
Tsuji A; Wakisaka N; Kondo S; Murono S; Furukawa M; Yoshizaki T
Clin Cancer Res; 2008 Sep; 14(17):5368-75. PubMed ID: 18765528
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
[TBL] [Abstract][Full Text] [Related]
20. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.
Ma W; Lee SE; Guo J; Qu W; Hudson BI; Schmidt AM; Barile GR
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1355-61. PubMed ID: 17325184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
